Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Pintó Sala

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 17, 2013
[Introduction]Xavier Pintó Sala
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 26, 2018
The concept of severe hypertriglyceridemia and its implications in clinical practiceXavier Pintó Sala, Virginia Esteve Luque
Medicina Clinica|June 25, 2017
Relationship between cardiovascular disease and dental pathology. Systematic reviewBeatriz González Navarro, Xavier Pintó Sala, Enric Jané Salas
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 3, 2014
[Atherogenic dyslipidemia and residual risk. State of the art in 2014]Jesús Millán Núñez-Cortés, Juan Pedro-Botet Montoya, Xavier Pintó Sala, et al.
Medicina Clinica|May 4, 2010
[Residual vascular risk: recommendations of the Spanish Initiative for the Reduction of Residual Risk]Jesús Millán Núñez-Cortés, Juan Pedro-Botet Montoya, Xavier Pintó Sala, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 4, 2015
[Statins diabetogenicity: are all the same? state of art]Joan Rius Tarruella, Jesús Millán Núñez-Cortés, Juan Pedro-Botet, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 25, 2014
[Effectivity and satisfaction with the treatment for dyslipidemia with pitavastatin. Multicentric, descriptive, post authorised and observational study (REINA study)]Luis Alberto Rodríguez Arroyo, Angel Díaz Rodríguez, Xavier Pintó Sala, et al.
Journal of Clinical Laboratory Analysis|August 28, 2016
APOE Variants E2, E3, and E4 Can Be Miscalled By Classical PCR-RFLP When The Christchurch Variant Is Also PresentBeatriz Candás-Estébanez, Ariadna Padró-Miquel, Cristina Ruiz-Iruela, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 29, 2018
Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitusAntonio Ruiz-García, Ezequiel Arranz-Martínez, Ignacio Morón-Merchante, et al.
Journal of Clinical Laboratory Analysis|March 22, 2020
Precipitated sdLDL: An easy method to estimate LDL particle sizeBárbara Fernández-Cidón, Beatriz Candás-Estébanez, Josep Ribalta, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 17, 2013
[Introduction]Xavier Pintó Sala
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 26, 2018
The concept of severe hypertriglyceridemia and its implications in clinical practiceXavier Pintó Sala, Virginia Esteve Luque
Medicina Clinica|June 25, 2017
Relationship between cardiovascular disease and dental pathology. Systematic reviewBeatriz González Navarro, Xavier Pintó Sala, Enric Jané Salas
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 3, 2014
[Atherogenic dyslipidemia and residual risk. State of the art in 2014]Jesús Millán Núñez-Cortés, Juan Pedro-Botet Montoya, Xavier Pintó Sala, et al.
Medicina Clinica|May 4, 2010
[Residual vascular risk: recommendations of the Spanish Initiative for the Reduction of Residual Risk]Jesús Millán Núñez-Cortés, Juan Pedro-Botet Montoya, Xavier Pintó Sala, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 4, 2015
[Statins diabetogenicity: are all the same? state of art]Joan Rius Tarruella, Jesús Millán Núñez-Cortés, Juan Pedro-Botet, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 25, 2014
[Effectivity and satisfaction with the treatment for dyslipidemia with pitavastatin. Multicentric, descriptive, post authorised and observational study (REINA study)]Luis Alberto Rodríguez Arroyo, Angel Díaz Rodríguez, Xavier Pintó Sala, et al.
Journal of Clinical Laboratory Analysis|August 28, 2016
APOE Variants E2, E3, and E4 Can Be Miscalled By Classical PCR-RFLP When The Christchurch Variant Is Also PresentBeatriz Candás-Estébanez, Ariadna Padró-Miquel, Cristina Ruiz-Iruela, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 29, 2018
Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitusAntonio Ruiz-García, Ezequiel Arranz-Martínez, Ignacio Morón-Merchante, et al.
Journal of Clinical Laboratory Analysis|March 22, 2020
Precipitated sdLDL: An easy method to estimate LDL particle sizeBárbara Fernández-Cidón, Beatriz Candás-Estébanez, Josep Ribalta, et al.
Pageof 3